Lv45
610 积分 2022-12-13 加入
A Phase II Randomized Study of CDX-1401, a Dendritic Cell Targeting NY-ESO-1 Vaccine, in Patients with Malignant Melanoma Pre-Treated with Recombinant CDX-301, a Recombinant Human Flt3 Ligand
24天前
已关闭
Dendritic cell-targeting polymer nanoparticle-based immunotherapy for cancer: A review
28天前
已完结
Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting
28天前
已完结
Express Delivery of Next-Generation CAR T Cells with Preserved Naive and Stemness Phenotypes for the Treatment of Aggressive Lymphomas
29天前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
29天前
已完结
As Fast As We Can: Rational Design of Rapid Chimeric Antigen Receptor T Cell Manufacturing
29天前
已关闭
Results from the First Phase 1 Clinical Study of the B-Cell Maturation Antigen (BCMA) Nex T Chimeric Antigen Receptor (CAR) T Cell Therapy CC-98633/BMS-986354 in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
29天前
已关闭
Manufacturing of CRISPR-edited primary mouse CAR T cells for cancer immunotherapy
1个月前
已完结
Rapid manufacturing of CAR-T therapy: strategies and impact
1个月前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
1个月前
已完结
皖公网安备34019202002308
